667 related articles for article (PubMed ID: 27456261)
21. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
Skoglund PH; Arpegård J; Ostergren J; Svensson P
Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
[TBL] [Abstract][Full Text] [Related]
22. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.
Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A
Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877
[TBL] [Abstract][Full Text] [Related]
23. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes.
Hillis GS; Welsh P; Chalmers J; Perkovic V; Chow CK; Li Q; Jun M; Neal B; Zoungas S; Poulter N; Mancia G; Williams B; Sattar N; Woodward M
Diabetes Care; 2014; 37(1):295-303. PubMed ID: 24089534
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
[TBL] [Abstract][Full Text] [Related]
25. Cardiac biomarkers predict mortality in emergency patients presenting with atrial fibrillation.
Niederdöckl J; Simon A; Schnaubelt S; Schuetz N; Laggner R; Sulzgruber P; Spiel AO; Herkner H; Laggner AN; Domanovits H
Heart; 2019 Mar; 105(6):482-488. PubMed ID: 30415208
[TBL] [Abstract][Full Text] [Related]
26. High-sensitive troponin T and N-terminal pro-B-type natriuretic peptide independently predict survival and cardiac-related events in adults with congenital heart disease.
Willinger L; Brudy L; Häcker AL; Meyer M; Hager A; Oberhoffer-Fritz R; Ewert P; Müller J
Eur J Cardiovasc Nurs; 2024 Jan; 23(1):55-61. PubMed ID: 36883916
[TBL] [Abstract][Full Text] [Related]
27. Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure.
Aimo A; Januzzi JL; Mueller C; Mirò O; Pascual Figal DA; Jacob J; Herrero-Puente P; Llorens P; Wussler D; Kozhuharov N; Sabti Z; Breidthardt T; Vergaro G; Ripoli A; Prontera C; Saccaro L; Passino C; Emdin M
Int J Cardiol; 2019 Oct; 293():137-142. PubMed ID: 31200964
[TBL] [Abstract][Full Text] [Related]
28. Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus.
Prausmüller S; Resl M; Arfsten H; Spinka G; Wurm R; Neuhold S; Bartko PE; Goliasch G; Strunk G; Pavo N; Clodi M; Hülsmann M
Cardiovasc Diabetol; 2021 Feb; 20(1):34. PubMed ID: 33530999
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.
Colombo M; Looker HC; Farran B; Agakov F; Brosnan MJ; Welsh P; Sattar N; Livingstone S; Durrington PN; Betteridge DJ; McKeigue PM; Colhoun HM
Atherosclerosis; 2018 Jul; 274():182-190. PubMed ID: 29793175
[TBL] [Abstract][Full Text] [Related]
30. NT-proBNP as a means of triage for the risk of hospitalisation in primary care.
Adlbrecht C; Neuhold S; Hülsmann M; Strunk G; Ehmsen U; Scholten C; Maurer G; Pacher R
Eur J Prev Cardiol; 2012 Feb; 19(1):55-61. PubMed ID: 21450621
[TBL] [Abstract][Full Text] [Related]
31. NT-proBNP in patients with out-of-hospital cardiac arrest: Results from the FINNRESUSCI Study.
Myhre PL; Tiainen M; Pettilä V; Vaahersalo J; Hagve TA; Kurola J; Varpula T; Omland T; Røsjø H;
Resuscitation; 2016 Jul; 104():12-8. PubMed ID: 27109503
[TBL] [Abstract][Full Text] [Related]
32. Predicting the outcome of hip fracture patients by using N-terminal fragment of pro-B-type natriuretic peptide.
Nordling P; Kiviniemi T; Strandberg M; Strandberg N; Airaksinen J
BMJ Open; 2016 Feb; 6(2):e009416. PubMed ID: 26911583
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease.
Baggen VJ; van den Bosch AE; Eindhoven JA; Schut AW; Cuypers JA; Witsenburg M; de Waart M; van Schaik RH; Zijlstra F; Boersma E; Roos-Hesselink JW
Circulation; 2017 Jan; 135(3):264-279. PubMed ID: 27832613
[TBL] [Abstract][Full Text] [Related]
34. Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes.
von Scholten BJ; Reinhard H; Hansen TW; Lindhardt M; Petersen CL; Wiinberg N; Hansen PR; Parving HH; Jacobsen PK; Rossing P
Cardiovasc Diabetol; 2015 May; 14():59. PubMed ID: 25990319
[TBL] [Abstract][Full Text] [Related]
35. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study.
Daniels LB; Clopton P; Laughlin GA; Maisel AS; Barrett-Connor E
Circulation; 2011 May; 123(19):2101-10. PubMed ID: 21536998
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of combining high sensitive troponin T and N-terminal pro B-type natriuretic peptide in chest pain patients with no persistent ST-elevation.
Melki D; Lind S; Agewall S; Jernberg T
Clin Chim Acta; 2012 May; 413(9-10):933-7. PubMed ID: 22366164
[TBL] [Abstract][Full Text] [Related]
37. Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.
Ballo P; Betti I; Barchielli A; Balzi D; Castelli G; De Luca L; Gheorghiade M; Zuppiroli A
Clin Res Cardiol; 2016 May; 105(5):421-31. PubMed ID: 26547915
[TBL] [Abstract][Full Text] [Related]
38. sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.
Emdin M; Aimo A; Vergaro G; Bayes-Genis A; Lupón J; Latini R; Meessen J; Anand IS; Cohn JN; Gravning J; Gullestad L; Broch K; Ueland T; Nymo SH; Brunner-La Rocca HP; de Boer RA; Gaggin HK; Ripoli A; Passino C; Januzzi JL
J Am Coll Cardiol; 2018 Nov; 72(19):2309-2320. PubMed ID: 30384887
[TBL] [Abstract][Full Text] [Related]
39. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
Ishigami J; Hoogeveen RC; Ballantyne CM; Folsom AR; Coresh J; Selvin E; Matsushita K
Am J Epidemiol; 2019 Dec; 188(12):2146-2155. PubMed ID: 31063194
[TBL] [Abstract][Full Text] [Related]
40. Blood-Based Cardiac Biomarkers and the Risk of Cognitive Decline, Cerebrovascular Disease, and Clinical Events.
Gyanwali B; Lai MKP; Lui B; Liew OW; Venketasubramanian N; Richards AM; Chen C; Hilal S
Stroke; 2021 Jul; 52(7):2275-2283. PubMed ID: 33971742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
